Hypercholesterolemia, autosomal dominant, 3
MONDO:0011369Any familial hypercholesterolemia in which the cause of the disease is a mutation in the PCSK9 gene.
Also known as: PCSK9 familial hypercholesterolemia, familial hypercholesterolemia caused by mutation in PCSK9, hypercholesterolemia, autosomal dominant, 3, hypercholesterolemia, autosomal dominant, type 3, hypercholesterolemia, familial, 3, low density lipoprotein cholesterol level QTL 1, Fh3, HCHOLA3
5 clinical trials for this condition and its sub-types, 4 tagged with Hypercholesterolemia, autosomal dominant, 3 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug combo aims to halt artery plaque after heart attacks
Disease control Recruiting nowThis study tests whether adding evolocumab, a cholesterol-lowering drug, to standard care can slow or stop plaque buildup in heart arteries after a heart attack. About 233 adults aged 40-75 who recently had a heart attack or unstable angina will receive either evolocumab plus sta…
Phase 4 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Fish oil may counteract hidden diabetes risk from low bad cholesterol
Knowledge-focused Recruiting nowThis study looks at why having low 'bad' cholesterol (LDL) might actually increase the risk of type 2 diabetes. Researchers think LDL entering fat tissue may cause problems that lead to diabetes. They will test if taking omega-3 fish oil supplements for 6 months can reduce that r…
Sponsor: Institut de Recherches Cliniques de Montreal • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC